Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw a significant stock decline, contrasting with broader market trends. Over the past week and month, the stock has experienced notable decreases, while year-to-date performance reflects a downturn. Despite challenges, the company has generated a return over the past year, though profits have declined.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. faced a challenging trading session, with a notable stock decline. Over the past week, the stock decreased significantly, contrasting with the broader market. Long-term performance shows substantial declines, yet the company achieved a positive return over the past year despite decreased profits.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has seen a notable rise in stock performance, gaining 7.41% on October 15, 2025. The company reported record operating cash flow of CNY 1,519.92 million and maintains a dividend payout ratio of 63.98%, reflecting its strong position in the pharmaceuticals sector.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw its stock decline significantly on October 13, 2025, reaching an intraday low. Despite mixed performance metrics, including a notable year-to-date gain and strong operating cash flow, the company has faced challenges over longer time frames while maintaining a solid market position.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw a significant stock performance increase on September 25, 2025, reaching an intraday high. Over the past year, the company has shown impressive growth, recovering from previous declines and reporting strong financial metrics, including substantial operating cash flow and a notable dividend payout ratio.